<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02071849</url>
  </required_header>
  <id_info>
    <org_study_id>TP-01-025</org_study_id>
    <nct_id>NCT02071849</nct_id>
  </id_info>
  <brief_title>HAART 200 Aortic Valve Annuloplasty Trial</brief_title>
  <official_title>HAART 200 Aortic Valve Annuloplasty During Bicuspid Aortic Valve Reconstruction Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biostable Science &amp; Engineering</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biostable Science &amp; Engineering</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The HAART 200 &quot;Aortic Annuloplasty during Bicuspid Aortic Valve Reconstruction&quot; Trial is a
      prospective, non-randomized, multi-center trial to evaluate the safety and effectiveness of
      the HAART 200 bicuspid annuloplasty ring when used to surgically stabilize the aortic valve
      annulus in patients undergoing repair of bicuspid aortic valves (BAV) for predominant aortic
      insufficiency (AI).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aortic valve disease is the most common valvular heart disease with approximately 200,000
      patients per year undergoing conventional aortic valve replacement in North America and
      Europe. Around 60% of valves have Aortic Stenosis (AS) and 40% of have Aortic Insufficiency,
      which is the failure of the aortic valve to close completely during diastole, causing blood
      to flow from the aorta back into the left ventricle. Bicuspid valve morphology is present in
      a fourth to a third of patients coming to surgical intervention, and constitutes a very
      important subset. Several conditions are associated with bicuspid disease, including
      ascending aortic or root aneurysms in up to a third.

      Traditional management of aortic valve and root disease has been with aortic valve
      replacement, with or without root replacement (Bentall Procedure). However, as has been
      observed in patients with mitral valve repair, the option of maintaining one's reconstructed
      native valve versus a replacement, either bioprosthetic or mechanical, can have multiple
      benefits. The advantages of repair include: the avoidance of prosthetic valve related
      complications and structural degeneration with bioprosthetic valves over 10-15 years and
      elimination of the need for anticoagulation and related problems with mechanical valves in
      younger patients. The significantly lower rate of endocarditis after repair is a major
      impetus to increasing performance of BAV reconstruction. Thus, aortic valve repair currently
      is established as an excellent option for patients with BAV. However, with connective tissue
      disorders being an inherent feature of BAV, outcomes have been less stable long-term than for
      trileaflet repair, primarily because of late annular redilatation in BAV disease.

      Therefore, this study is designed to evaluate the safety and effectiveness of annular
      stabilization with a bicuspid annuloplasty ring in patients undergoing repair of a bicuspid
      aortic valve for predominant aortic insufficiency.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Safety Outcome Measure: Survival Defined as Survival Free From All Cause Death at 6 Months Postprocedure.</measure>
    <time_frame>6 months postprocedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary Efficacy Outcome Measure: Aortic Insufficiency (AI) at 6 Months</measure>
    <time_frame>6 months postprocedure</time_frame>
    <description>Aortic insufficiency assessed by transthoracic echocardiography and graded as None/Trace (0), Mild (1+), Moderate (2+), Moderately Severe (3+), or Severe (4+)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Implant Procedure Success</measure>
    <time_frame>discharge or 14 days postprocedure, whichever comes first</time_frame>
    <description>Success is defined as the absence of specified adverse events evaluated through discharge following the procedure: - Aortic annular dissection, rupture, or leaflet damage - Mitral valve impingement due to implant - implant dehiscence/migration into aorta - implant dehiscence/migration into left ventricle - Hemodynamics requiring intervention - Other adverse event resulting in reoperation, explantation, or permanent disability.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Actuarial Freedom From Clinical Cardiovascular Events</measure>
    <time_frame>6 months postprocedure</time_frame>
    <description>Freedom from specified clinical cardiovascular events 6 months postprocedure: - Device-related mortality - Complete heart block - Structural device failure - Endocarditis - Periprosthetic leak or dehiscence - Thromboembolism - Bleeding Event - Native Valve Deterioration - Valve Thrombosis - Hemolysis - Reoperation and explant at 6 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Actuarial Freedom From Clinical Cardiovascular Events</measure>
    <time_frame>2 years postprocedure</time_frame>
    <description>Freedom from specified clinical cardiovascular events 6 months postprocedure: - Device-related mortality - Complete heart block - Structural device failure - Endocarditis - Periprosthetic leak or dehiscence - Thromboembolism - Bleeding Event - Native Valve Deterioration - Valve Thrombosis - Hemolysis - Reoperation and explant at 6 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival Defined as Survival Free From All Cause Death at 2 Years Postprocedure.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aortic Insufficiency (AI) at 2 Years</measure>
    <time_frame>Baseline and 2 years</time_frame>
    <description>Aortic insufficiency assessed by transthoracic echocardiography and graded as None/Trace (0), Mild (1+), Moderate (2+), Moderate-to-Severe (3+), or Severe (4+)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New York Heart Association (NYHA) Functional Capacity Classification</measure>
    <time_frame>6 months postprocedure</time_frame>
    <description>Four classes describing the effect of cardiac disease on physical activity: Class I - disease does not limit activity; Class II - slight limitation; Class III - marked limitation; Class IV - inability to carry out any physical activity without discomfort</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NYHA Functional Capacity Classification</measure>
    <time_frame>2 years postprocedure</time_frame>
    <description>Four classes describing the effect of cardiac disease on physical activity: Class I - disease does not limit activity; Class II - slight limitation; Class III - marked limitation; Class IV - inability to carry out any physical activity without discomfort</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak Gradient - Change From Baseline</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>Transthoracic echocardiography parameter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak Gradient - Change From Baseline</measure>
    <time_frame>Baseline and 2 years</time_frame>
    <description>Transthoracic echocardiography parameter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Gradient - Change From Baseline</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>Transthoracic echocardiography parameter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Gradient - Change From Baseline</measure>
    <time_frame>Baseline and 2 years</time_frame>
    <description>Transthoracic echocardiography parameter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left Ventricular (LV) Mass - Change From Baseline</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>Left ventricular mass. Transthoracic echocardiography parameter.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LV Mass - Change From Baseline</measure>
    <time_frame>Baseline and 2 years</time_frame>
    <description>Left ventricular mass. Transthoracic echocardiography parameter.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left Ventricular Internal Dimension (LVID) Diastole - Change From Baseline</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>Left ventricular internal dimension. Transthoracic echocardiography parameter.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LVID Diastole - Change From Baseline</measure>
    <time_frame>Baseline and 2 years</time_frame>
    <description>Left ventricular internal dimension. Transthoracic echocardiography parameter.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LVID Systole - Change From Baseline</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>Left ventricular internal dimension. Transthoracic echocardiography parameter.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LVID Systole - Change From Baseline</measure>
    <time_frame>Baseline and 2 years</time_frame>
    <description>Left ventricular internal dimension. Transthoracic echocardiography parameter.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LV Diastolic Volume - Change From Baseline</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>Left ventricular diastolic volume. Transthoracic echocardiography parameter.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LV Diastolic Volume - Change From Baseline</measure>
    <time_frame>Baseline and 2 years</time_frame>
    <description>Left ventricular diastolic volume. Transthoracic echocardiography parameter.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LV Systolic Volume - Change From Baseline</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>Left ventricular systolic volume. Transthoracic echocardiography parameter.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LV Systolic Volume - Change From Baseline</measure>
    <time_frame>Baseline and 2 years</time_frame>
    <description>Left ventricular systolic volume. Transthoracic echocardiography parameter.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left Ventricular Ejection Fraction (LVEF) - Change From Baseline</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>Left ventricular ejection fraction. Transthoracic echocardiography parameter.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left Ventricular Ejection Fraction (LVEF) - Change From Baseline</measure>
    <time_frame>Baseline and 2 years</time_frame>
    <description>Left ventricular ejection fraction. Transthoracic echocardiography parameter.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac Output - Change From Baseline</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>Stroke volume x heart rate. Transthoracic echocardiography parameter.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac Output - Change From Baseline</measure>
    <time_frame>Baseline and 2 years</time_frame>
    <description>Stroke volume x heart rate. Transthoracic echocardiography parameter.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac Index - Change From Baseline</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>Hemodynamic parameter computed as cardiac output divided by body surface area</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac Index - Change From Baseline</measure>
    <time_frame>Baseline and 2 years</time_frame>
    <description>Hemodynamic parameter computed as cardiac output divided by body surface area</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Aortic Insufficiency</condition>
  <arm_group>
    <arm_group_label>Aortic Valve Repair</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HAART 200 Aortic Valve Annuloplasty Device</intervention_name>
    <description>Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
    <arm_group_label>Aortic Valve Repair</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The subject is 18 years of age or older

          2. The subject has bi-leaflet aortic valve morphology

          3. The subject has documented aortic valve disease which may or may not include:

               -  Aortic valve insufficiency

               -  Ascending aortic or aortic root pathology

               -  Other pathology of the ascending aorta that requires elective aortic replacement

               -  Associated stable one or two vessel coronary disease requiring concomitant
                  coronary bypass

               -  Patients with recurrent severe AI (Grade 3 or 4) after prior bicuspid repair who
                  are undergoing re-repair because of annular re-dilatation

               -  All bicuspid annular and leaflet configurations will be included

          4. The subject needs:

               -  correction of BAV annular dilatation in patients with chronic AI and dilated
                  annulus

               -  restoration of a circular annular shape in patients with bicuspid valve and
                  expansion of sinus to sinus dimensions

               -  stabilization of annular geometry long-term in rare bicuspid valve patients with
                  severe AI and minimal annular dilatation

          5. The is willing to comply with specified follow-up evaluations, including
             transesophageal echocardiography (TEE) if there are inadequate images by transthoracic
             echocardiography (TTE) to assess the aortic valve

          6. The subject has reviewed and signed the written informed consent form

          7. The subject agrees to return for all follow-up evaluations for the duration of the
             study (i.e. geographically stable)

        Exclusion Criteria:

          1. All patients will be excluded who require emergency surgery for any reason.

          2. All the patients who have had a prior heart valve replacement

          3. The subject's aortic valve morphology is not bicuspid.

          4. The subject has active endocarditis

          5. The subject has mixed stenosis and regurgitation of the aortic valve with predominant
             stenosis

          6. Heavily calcified BAV valves, calcified aortic roots, or &quot;porcelain aortas&quot;

          7. Leukopenia with a White Blood Cell (WBC) of less than 3000

          8. Acute anemia with a Hgb less than 9mg%

          9. Platelet count less than 100,000 cells/mm3

         10. History of a defined bleeding diathesis or coagulopathy or the subject refuses blood
             transfusions

         11. Active infection requiring antibiotic therapy (if temporary illness, subjects may
             enroll 2-4 weeks after discontinuation of antibiotics)

         12. Subjects in whom transesophageal echocardiography (TEE) is contraindicated

         13. Low Ejection Fraction (EF) &lt; 35%

         14. Life expectancy &lt; 1 year, or severe comorbidities, such as dialysis or severe Chronic
             Obstructive Pulmonary Disease (COPD)

         15. The subject is or will be participating in a concomitant research study of an
             investigational product or has participated in such a study within the 30 days prior
             to screening

         16. The subject is a minor, an illicit drug user, alcohol abuser, prisoner,
             institutionalized, or is unable to give informed consent

         17. The subject is pregnant or lactating

         18. Recent (within 6 months) cerebrovascular accident (CVA) or a transient ischemic attack
             (TIA)

         19. Myocardial Infarction (MI) within one month of trial inclusion

         20. The subject has a known intolerance to titanium or polyester

         21. The subject has documented unstable or &gt; 2 vessel coronary disease

         22. The subject requires additional valve replacement or valve repair
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dominico Mazzitelli, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>München Heart Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>München Heart Center</name>
      <address>
        <city>München</city>
        <state>Bavaria</state>
        <zip>80636</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Uniklinik Köln</name>
      <address>
        <city>Köln</city>
        <state>North Rhine-Westphalia</state>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik und Poliklinik für Herz- und Gefäßchirurgie</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Nürnberg Süd</name>
      <address>
        <city>Nürnberg</city>
        <zip>90471</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 17, 2014</study_first_submitted>
  <study_first_submitted_qc>February 25, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 26, 2014</study_first_posted>
  <results_first_submitted>January 30, 2017</results_first_submitted>
  <results_first_submitted_qc>January 30, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">March 20, 2017</results_first_posted>
  <last_update_submitted>March 20, 2017</last_update_submitted>
  <last_update_submitted_qc>March 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aortic Insufficiency</keyword>
  <keyword>Aortic Regurgitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Aortic Valve Repair</title>
          <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>6-month Primary Endpoint</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Did not receive device</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>2-year Extended Follow-up</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>16 of 20 consented participants received the device</population>
      <group_list>
        <group group_id="B1">
          <title>Aortic Valve Repair</title>
          <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="16"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44.4" spread="11.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>18-29</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30-39</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>40-49</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>50-59</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60-69</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Germany</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Aortic Insufficiency</title>
          <description>Grade assigned to degree of aortic regurgitation determined by core laboratory analysis of echocardiogram:
0=None/trace,1+=Mild, 2+=Moderate, 3+=Moderately Severe, 4+=Severe</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>0</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1+</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2+</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3+</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4+</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade not available</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>New York Heart Association (NYHA) Functional Capacity</title>
          <description>Four classes describing the effect of cardiac disease on physical activity: Class I - disease does not limit activity; Class II - slight limitation; Class III - marked limitation; Class IV - inability to carry out any physical activity without discomfort</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>II</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>III</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IV</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Peak gradient</title>
          <description>Echocardiographic parameter determined by core laboratory.</description>
          <population>Participants with an echocardiogram evaluable for this measure.</population>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25.5" spread="22.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mean gradient</title>
          <description>Echocardiographic parameter determined by core laboratory.</description>
          <population>Participants with an echocardiogram evaluable for this measure.</population>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13.4" spread="12.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Left ventricular (LV) mass</title>
          <description>Left ventricular mass. Echocardiographic parameter determined by core laboratory.</description>
          <population>Participants with an echocardiogram evaluable for this measure.</population>
          <units>g</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="288.62" spread="90.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Left ventricular internal dimension (LVID) diastole</title>
          <description>Left ventricular internal dimension. Echocardiographic parameter determined by core laboratory.</description>
          <population>Participants with an echocardiogram evaluable for this measure.</population>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.408" spread="0.952"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>LVID systole</title>
          <description>Left ventricular internal dimension. Echocardiographic parameter determined by core laboratory.</description>
          <population>Participants with an echocardiogram evaluable for this measure.</population>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.527" spread="0.793"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>LV diastolic volume</title>
          <description>Left ventricular diastolic volume. Echocardiographic parameter determined by core laboratory.</description>
          <population>Participants with an echocardiogram evaluable for this measure.</population>
          <units>ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="144.5" spread="57.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>LV systolic volume</title>
          <description>Left ventricular systolic volume. Echocardiographic parameter determined by core laboratory.</description>
          <population>Participants with an echocardiogram evaluable for this measure.</population>
          <units>ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69.1" spread="36.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Left ventricular ejection fraction (LVEF)</title>
          <description>Left ventricular ejection fraction. Echocardiographic parameter determined by core laboratory.</description>
          <population>Participants with an echocardiogram evaluable for this measure.</population>
          <units>percentage of blood volume</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53.86" spread="8.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cardiac output</title>
          <description>Echocardiographic parameter determined by core laboratory.</description>
          <population>Participants with an echocardiogram evaluable for this measure.</population>
          <units>l/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.926" spread="2.365"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cardiac index</title>
          <description>Cardiac index is the cardiac output divided by body surface area.</description>
          <population>Participants with an echocardiogram evaluable for this measure.</population>
          <units>l/min/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.88" spread="1.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Primary Safety Outcome Measure: Survival Defined as Survival Free From All Cause Death at 6 Months Postprocedure.</title>
        <time_frame>6 months postprocedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>Primary Safety Outcome Measure: Survival Defined as Survival Free From All Cause Death at 6 Months Postprocedure.</title>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="79.4" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Primary Efficacy Outcome Measure: Aortic Insufficiency (AI) at 6 Months</title>
        <description>Aortic insufficiency assessed by transthoracic echocardiography and graded as None/Trace (0), Mild (1+), Moderate (2+), Moderately Severe (3+), or Severe (4+)</description>
        <time_frame>6 months postprocedure</time_frame>
        <population>Participants with an echocardiogram evaluable for this measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>Primary Efficacy Outcome Measure: Aortic Insufficiency (AI) at 6 Months</title>
          <description>Aortic insufficiency assessed by transthoracic echocardiography and graded as None/Trace (0), Mild (1+), Moderate (2+), Moderately Severe (3+), or Severe (4+)</description>
          <population>Participants with an echocardiogram evaluable for this measure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1+</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2+</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3+</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4+</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Implant Procedure Success</title>
        <description>Success is defined as the absence of specified adverse events evaluated through discharge following the procedure: - Aortic annular dissection, rupture, or leaflet damage - Mitral valve impingement due to implant - implant dehiscence/migration into aorta - implant dehiscence/migration into left ventricle - Hemodynamics requiring intervention - Other adverse event resulting in reoperation, explantation, or permanent disability.</description>
        <time_frame>discharge or 14 days postprocedure, whichever comes first</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>Implant Procedure Success</title>
          <description>Success is defined as the absence of specified adverse events evaluated through discharge following the procedure: - Aortic annular dissection, rupture, or leaflet damage - Mitral valve impingement due to implant - implant dehiscence/migration into aorta - implant dehiscence/migration into left ventricle - Hemodynamics requiring intervention - Other adverse event resulting in reoperation, explantation, or permanent disability.</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="79.4" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Actuarial Freedom From Clinical Cardiovascular Events</title>
        <description>Freedom from specified clinical cardiovascular events 6 months postprocedure: - Device-related mortality - Complete heart block - Structural device failure - Endocarditis - Periprosthetic leak or dehiscence - Thromboembolism - Bleeding Event - Native Valve Deterioration - Valve Thrombosis - Hemolysis - Reoperation and explant at 6 months</description>
        <time_frame>6 months postprocedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>Actuarial Freedom From Clinical Cardiovascular Events</title>
          <description>Freedom from specified clinical cardiovascular events 6 months postprocedure: - Device-related mortality - Complete heart block - Structural device failure - Endocarditis - Periprosthetic leak or dehiscence - Thromboembolism - Bleeding Event - Native Valve Deterioration - Valve Thrombosis - Hemolysis - Reoperation and explant at 6 months</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.5" lower_limit="58.6" upper_limit="96.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Actuarial Freedom From Clinical Cardiovascular Events</title>
        <description>Freedom from specified clinical cardiovascular events 6 months postprocedure: - Device-related mortality - Complete heart block - Structural device failure - Endocarditis - Periprosthetic leak or dehiscence - Thromboembolism - Bleeding Event - Native Valve Deterioration - Valve Thrombosis - Hemolysis - Reoperation and explant at 6 months</description>
        <time_frame>2 years postprocedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>Actuarial Freedom From Clinical Cardiovascular Events</title>
          <description>Freedom from specified clinical cardiovascular events 6 months postprocedure: - Device-related mortality - Complete heart block - Structural device failure - Endocarditis - Periprosthetic leak or dehiscence - Thromboembolism - Bleeding Event - Native Valve Deterioration - Valve Thrombosis - Hemolysis - Reoperation and explant at 6 months</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.2" lower_limit="52.5" upper_limit="93.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Survival Defined as Survival Free From All Cause Death at 2 Years Postprocedure.</title>
        <time_frame>2 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>Survival Defined as Survival Free From All Cause Death at 2 Years Postprocedure.</title>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="79.4" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Aortic Insufficiency (AI) at 2 Years</title>
        <description>Aortic insufficiency assessed by transthoracic echocardiography and graded as None/Trace (0), Mild (1+), Moderate (2+), Moderate-to-Severe (3+), or Severe (4+)</description>
        <time_frame>Baseline and 2 years</time_frame>
        <population>Participants with an echocardiogram evaluable for this measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>Aortic Insufficiency (AI) at 2 Years</title>
          <description>Aortic insufficiency assessed by transthoracic echocardiography and graded as None/Trace (0), Mild (1+), Moderate (2+), Moderate-to-Severe (3+), or Severe (4+)</description>
          <population>Participants with an echocardiogram evaluable for this measure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1+</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2+</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3+</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4+</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>New York Heart Association (NYHA) Functional Capacity Classification</title>
        <description>Four classes describing the effect of cardiac disease on physical activity: Class I - disease does not limit activity; Class II - slight limitation; Class III - marked limitation; Class IV - inability to carry out any physical activity without discomfort</description>
        <time_frame>6 months postprocedure</time_frame>
        <population>Participants with an evaluation of this measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>New York Heart Association (NYHA) Functional Capacity Classification</title>
          <description>Four classes describing the effect of cardiac disease on physical activity: Class I - disease does not limit activity; Class II - slight limitation; Class III - marked limitation; Class IV - inability to carry out any physical activity without discomfort</description>
          <population>Participants with an evaluation of this measure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>I</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>II</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>III</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>NYHA Functional Capacity Classification</title>
        <description>Four classes describing the effect of cardiac disease on physical activity: Class I - disease does not limit activity; Class II - slight limitation; Class III - marked limitation; Class IV - inability to carry out any physical activity without discomfort</description>
        <time_frame>2 years postprocedure</time_frame>
        <population>Participants with an evaluation of this measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>NYHA Functional Capacity Classification</title>
          <description>Four classes describing the effect of cardiac disease on physical activity: Class I - disease does not limit activity; Class II - slight limitation; Class III - marked limitation; Class IV - inability to carry out any physical activity without discomfort</description>
          <population>Participants with an evaluation of this measure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>I</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>II</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>III</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Peak Gradient - Change From Baseline</title>
        <description>Transthoracic echocardiography parameter</description>
        <time_frame>Baseline and 6 months</time_frame>
        <population>Participants with an echocardiogram evaluable for this measure at baseline and at 6 months.</population>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>Peak Gradient - Change From Baseline</title>
          <description>Transthoracic echocardiography parameter</description>
          <population>Participants with an echocardiogram evaluable for this measure at baseline and at 6 months.</population>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1" spread="22.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Peak Gradient - Change From Baseline</title>
        <description>Transthoracic echocardiography parameter</description>
        <time_frame>Baseline and 2 years</time_frame>
        <population>Participants with an echocardiogram evaluable for this measure at baseline and at 2 years.</population>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>Peak Gradient - Change From Baseline</title>
          <description>Transthoracic echocardiography parameter</description>
          <population>Participants with an echocardiogram evaluable for this measure at baseline and at 2 years.</population>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" spread="16.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Gradient - Change From Baseline</title>
        <description>Transthoracic echocardiography parameter</description>
        <time_frame>Baseline and 6 months</time_frame>
        <population>Participants with an echocardiogram evaluable for this measure at baseline and at 6 months.</population>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Gradient - Change From Baseline</title>
          <description>Transthoracic echocardiography parameter</description>
          <population>Participants with an echocardiogram evaluable for this measure at baseline and at 6 months.</population>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="13.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Gradient - Change From Baseline</title>
        <description>Transthoracic echocardiography parameter</description>
        <time_frame>Baseline and 2 years</time_frame>
        <population>Participants with an echocardiogram evaluable for this measure at baseline and at 2 years.</population>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Gradient - Change From Baseline</title>
          <description>Transthoracic echocardiography parameter</description>
          <population>Participants with an echocardiogram evaluable for this measure at baseline and at 2 years.</population>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" spread="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Left Ventricular (LV) Mass - Change From Baseline</title>
        <description>Left ventricular mass. Transthoracic echocardiography parameter.</description>
        <time_frame>Baseline and 6 months</time_frame>
        <population>Participants with an echocardiogram evaluable for this measure at baseline and at 6 months.</population>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>Left Ventricular (LV) Mass - Change From Baseline</title>
          <description>Left ventricular mass. Transthoracic echocardiography parameter.</description>
          <population>Participants with an echocardiogram evaluable for this measure at baseline and at 6 months.</population>
          <units>g</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-53.98" spread="76.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>LV Mass - Change From Baseline</title>
        <description>Left ventricular mass. Transthoracic echocardiography parameter.</description>
        <time_frame>Baseline and 2 years</time_frame>
        <population>Participants with an echocardiogram evaluable for this measure at baseline and at 2 years.</population>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>LV Mass - Change From Baseline</title>
          <description>Left ventricular mass. Transthoracic echocardiography parameter.</description>
          <population>Participants with an echocardiogram evaluable for this measure at baseline and at 2 years.</population>
          <units>g</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-78.84" spread="88.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Left Ventricular Internal Dimension (LVID) Diastole - Change From Baseline</title>
        <description>Left ventricular internal dimension. Transthoracic echocardiography parameter.</description>
        <time_frame>Baseline and 6 months</time_frame>
        <population>Participants with an echocardiogram evaluable for this measure at baseline and at 6 months.</population>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>Left Ventricular Internal Dimension (LVID) Diastole - Change From Baseline</title>
          <description>Left ventricular internal dimension. Transthoracic echocardiography parameter.</description>
          <population>Participants with an echocardiogram evaluable for this measure at baseline and at 6 months.</population>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.306" spread="0.843"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>LVID Diastole - Change From Baseline</title>
        <description>Left ventricular internal dimension. Transthoracic echocardiography parameter.</description>
        <time_frame>Baseline and 2 years</time_frame>
        <population>Participants with an echocardiogram evaluable for this measure at baseline and at 2 years.</population>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>LVID Diastole - Change From Baseline</title>
          <description>Left ventricular internal dimension. Transthoracic echocardiography parameter.</description>
          <population>Participants with an echocardiogram evaluable for this measure at baseline and at 2 years.</population>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.455" spread="1.023"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>LVID Systole - Change From Baseline</title>
        <description>Left ventricular internal dimension. Transthoracic echocardiography parameter.</description>
        <time_frame>Baseline and 6 months</time_frame>
        <population>Participants with an echocardiogram evaluable for this measure at baseline and at 6 months.</population>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>LVID Systole - Change From Baseline</title>
          <description>Left ventricular internal dimension. Transthoracic echocardiography parameter.</description>
          <population>Participants with an echocardiogram evaluable for this measure at baseline and at 6 months.</population>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.030" spread="0.531"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>LVID Systole - Change From Baseline</title>
        <description>Left ventricular internal dimension. Transthoracic echocardiography parameter.</description>
        <time_frame>Baseline and 2 years</time_frame>
        <population>Participants with an echocardiogram evaluable for this measure at baseline and at 2 years.</population>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>LVID Systole - Change From Baseline</title>
          <description>Left ventricular internal dimension. Transthoracic echocardiography parameter.</description>
          <population>Participants with an echocardiogram evaluable for this measure at baseline and at 2 years.</population>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.700" spread="1.108"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>LV Diastolic Volume - Change From Baseline</title>
        <description>Left ventricular diastolic volume. Transthoracic echocardiography parameter.</description>
        <time_frame>Baseline and 6 months</time_frame>
        <population>Participants with an echocardiogram evaluable for this measure at baseline and at 6 months.</population>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>LV Diastolic Volume - Change From Baseline</title>
          <description>Left ventricular diastolic volume. Transthoracic echocardiography parameter.</description>
          <population>Participants with an echocardiogram evaluable for this measure at baseline and at 6 months.</population>
          <units>ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.8" spread="41.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>LV Diastolic Volume - Change From Baseline</title>
        <description>Left ventricular diastolic volume. Transthoracic echocardiography parameter.</description>
        <time_frame>Baseline and 2 years</time_frame>
        <population>Participants with an echocardiogram evaluable for this measure at baseline and at 2 years.</population>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>LV Diastolic Volume - Change From Baseline</title>
          <description>Left ventricular diastolic volume. Transthoracic echocardiography parameter.</description>
          <population>Participants with an echocardiogram evaluable for this measure at baseline and at 2 years.</population>
          <units>ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.9" spread="40.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>LV Systolic Volume - Change From Baseline</title>
        <description>Left ventricular systolic volume. Transthoracic echocardiography parameter.</description>
        <time_frame>Baseline and 6 months</time_frame>
        <population>Participants with an echocardiogram evaluable for this measure at baseline and at 6 months.</population>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>LV Systolic Volume - Change From Baseline</title>
          <description>Left ventricular systolic volume. Transthoracic echocardiography parameter.</description>
          <population>Participants with an echocardiogram evaluable for this measure at baseline and at 6 months.</population>
          <units>ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="25.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>LV Systolic Volume - Change From Baseline</title>
        <description>Left ventricular systolic volume. Transthoracic echocardiography parameter.</description>
        <time_frame>Baseline and 2 years</time_frame>
        <population>Participants with an echocardiogram evaluable for this measure at baseline and at 2 years.</population>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>LV Systolic Volume - Change From Baseline</title>
          <description>Left ventricular systolic volume. Transthoracic echocardiography parameter.</description>
          <population>Participants with an echocardiogram evaluable for this measure at baseline and at 2 years.</population>
          <units>ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.9" spread="24.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Left Ventricular Ejection Fraction (LVEF) - Change From Baseline</title>
        <description>Left ventricular ejection fraction. Transthoracic echocardiography parameter.</description>
        <time_frame>Baseline and 6 months</time_frame>
        <population>Participants with an echocardiogram evaluable for this measure at baseline and at 6 months.</population>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>Left Ventricular Ejection Fraction (LVEF) - Change From Baseline</title>
          <description>Left ventricular ejection fraction. Transthoracic echocardiography parameter.</description>
          <population>Participants with an echocardiogram evaluable for this measure at baseline and at 6 months.</population>
          <units>percentage of blood volume</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="8.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Left Ventricular Ejection Fraction (LVEF) - Change From Baseline</title>
        <description>Left ventricular ejection fraction. Transthoracic echocardiography parameter.</description>
        <time_frame>Baseline and 2 years</time_frame>
        <population>Participants with an echocardiogram evaluable for this measure at baseline and at 2 years.</population>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>Left Ventricular Ejection Fraction (LVEF) - Change From Baseline</title>
          <description>Left ventricular ejection fraction. Transthoracic echocardiography parameter.</description>
          <population>Participants with an echocardiogram evaluable for this measure at baseline and at 2 years.</population>
          <units>percentage of blood volume</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.21" spread="10.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cardiac Output - Change From Baseline</title>
        <description>Stroke volume x heart rate. Transthoracic echocardiography parameter.</description>
        <time_frame>Baseline and 6 months</time_frame>
        <population>Participants with an echocardiogram evaluable for this measure at baseline and at 6 months.</population>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>Cardiac Output - Change From Baseline</title>
          <description>Stroke volume x heart rate. Transthoracic echocardiography parameter.</description>
          <population>Participants with an echocardiogram evaluable for this measure at baseline and at 6 months.</population>
          <units>l/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.932" spread="2.979"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cardiac Output - Change From Baseline</title>
        <description>Stroke volume x heart rate. Transthoracic echocardiography parameter.</description>
        <time_frame>Baseline and 2 years</time_frame>
        <population>Participants with an echocardiogram evaluable for this measure at baseline and at 2 years.</population>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>Cardiac Output - Change From Baseline</title>
          <description>Stroke volume x heart rate. Transthoracic echocardiography parameter.</description>
          <population>Participants with an echocardiogram evaluable for this measure at baseline and at 2 years.</population>
          <units>l/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.145" spread="2.679"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cardiac Index - Change From Baseline</title>
        <description>Hemodynamic parameter computed as cardiac output divided by body surface area</description>
        <time_frame>Baseline and 6 months</time_frame>
        <population>Participants with an echocardiogram evaluable for this measure at baseline and at 6 months.</population>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>Cardiac Index - Change From Baseline</title>
          <description>Hemodynamic parameter computed as cardiac output divided by body surface area</description>
          <population>Participants with an echocardiogram evaluable for this measure at baseline and at 6 months.</population>
          <units>l/min/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.50" spread="1.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cardiac Index - Change From Baseline</title>
        <description>Hemodynamic parameter computed as cardiac output divided by body surface area</description>
        <time_frame>Baseline and 2 years</time_frame>
        <population>Participants with an echocardiogram evaluable for this measure at baseline and at 2 years.</population>
        <group_list>
          <group group_id="O1">
            <title>Aortic Valve Repair</title>
            <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
          </group>
        </group_list>
        <measure>
          <title>Cardiac Index - Change From Baseline</title>
          <description>Hemodynamic parameter computed as cardiac output divided by body surface area</description>
          <population>Participants with an echocardiogram evaluable for this measure at baseline and at 2 years.</population>
          <units>l/min/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.09" spread="1.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 years</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Aortic Valve Repair</title>
          <description>Implantation of HAART 200 Aortic Valve Annuloplasty Device for bicuspid aortic valve reconstruction
HAART 200 Aortic Valve Annuloplasty Device: Surgical repair of bicuspid aortic valve using the HAART 200 Aortic Valve Annuloplasty Device .</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (14.1)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic vlave incompetence</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Thermal burn</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Chronic lymphocytic leukemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA (14.1)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic valve incompetence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Impaired healing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Laboratory test abnormal</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic dilation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Publication by the investigator was not allowed until completion of the trial. All proposed publications must be cleared by unanimous vote of a publication committee consisting of the sponsor and representatives of the study investigators. Publication materials must be submitted for review at least 60 day in advance of publication. The Sponsor may embargo publication for 60 additional days to allow for patent filing or may prevent publication if filling of such application would be premature.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>John Wheeler</name_or_title>
      <organization>Biostable Science and Engineering, Inc.</organization>
      <phone>512-386-1996</phone>
      <email>John.wheeler@biostable-s-e.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

